Praxbind®
idarucizumab
About Praxbind®
Praxbind® is a specific reversal agent for dabigatran and is indicated in adult patients treated with Pradaxa® (dabigatran etexilate) when rapid reversal of its anticoaculant effects is required: for emergency surgery/urgent procedures; in life-threatening or uncontrolled bleeding.
Professional Area
You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.
Product Key Facts
Indications
Specific reversal of Pradaxa® (dabigatran etexilate)
Brand Names
Praxbind®
Active ingredients
idarucizumab